Editorial Bioteck
29 November 2023
Today we present further clinical evidence of the efficacy of CHondroGrid® in the treatment of knee osteoarthrosis.
The novelty lies in the comparison of the efficacy of CHondroGrid® with PRP and hyaluronic acid. The comparative clinical trial involved 75 patients (25 patients per treatment) with knee osteoarthrosis, mainly Kellgren-Lawrence grades 1-3.
CHondroGrid® consists of 4 mg of freeze-dried, low-molecular-weight (<3.3 kDa) collagen peptides to be resuspended in 2 ml of water for injection. Once injected, the peptides quickly diffuse into the tissue going directly to reinforce the extracellular matrix.
The results of the study at 6-month follow-up, show that CHondroGrid® is more effective than hyaluronic acid and PRP in reducing pain and functional recovery.
In patients treated with CHondroGrid®, a 50% reduction in pain is observed as early as 15 days after the first injection…
> Click here to download the clinical leaflet
Vicenza
Headquarter
via E. Fermi, 49
36057 Arcugnano, Vicenza (VI) - Italy
Tel. +39 0444 289366
Fax: +39 0444 285272
Torino
Multi-function production center
Via G. Agnelli, 3
10020 Riva presso Chieri, Torino (TO) - Italy
Copyright © 2026 Bioteck S.p.A. - Privacy Policy - Cookie Policy